7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,876.77

+511.14

+0.66%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

Paris - Delayed Quote EUR

Sartorius Stedim Biotech S.A. (DIM.PA)

223.40 -5.00 (-2.19%)

At close: October 30 at 5:35:21 PM GMT+1

Loading Chart for DIM.PA

Chart Range Bar

Interval:

In partnership with ChartIQ

Sartorius Stedim Biotech (ENXTPA:DIM) Q3 Earnings Confront A Premium Valuation

Sartorius Stedim Biotech (ENXTPA:DIM) Q3 Earnings Confront A Premium Valuation

Sartorius shares rise as Q3 beats on lab products surge, lab outlook raised

Sartorius shares rise as Q3 beats on lab products surge, lab outlook raised

OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director

OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director

European Stocks Possibly Trading Below Estimated Value May 2026

European Stocks Possibly Trading Below Estimated Value May 2026

[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Mobilize your Website

View Site in Mobile | Classic

Share by: